Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-16

FDA Approved: FEXINIDAZOLE — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved fexinidazole (Sanofi-Aventis U.S. LLC) for the treatment of human African trypanosomiasis (sleeping sickness) in the United States as an Original A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

ORIG AP for FEXINIDAZOLE (FEXINIDAZOLE)